BioCentury
ARTICLE | Financial News

China's Adagene raises $8M in series A

December 10, 2014 2:59 AM UTC

Adagene Inc. (Suzhou, China) raised $8 million in series A funding from Fidelity Biosciences; Fidelity Growth Partners Asia; and WuXi Venture Fund, the investment arm of Chinese CRO WuXi PharmaTech Inc. (NYSE:WX).

Adagene uses its Smart Antibody Technology platform to develop antibodies with enhanced safety and potency. It has yet to reveal any pipeline candidates. ...